Biobanks Market Report
RA08869
Biobanks Market by Product (Biobanking Equipment, Biobanking Consumables, and Laboratory Information Management Systems), Service (Biobanking & Repository, Lab Processing, Qualification/ Validation, Cold Chain Logistics, and Other Services), Biospecimen Type (Human Tissues, Human Organs, Stem Cells, and Other Biospecimens), Biobank Type (Physical/Real Biobanks, and Virtual Biobanks), Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, and Other Applications), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Biobanks Overview
A biobank is a valuable repository of biological samples and associated data carefully collected and stored for scientific research purposes. Biobanks store a wide range of biological materials such as blood & tissue, DNA & cells, and even body fluids. These samples are usually collected from consenting individuals who agree to contribute their specimens for research purposes. The data linked to these samples are also crucial as they provide valuable insights into the donors' health history & lifestyle and genetic background. Researchers utilize these biobanks to investigate various diseases and conditions. Moreover, researchers and pharmaceutical companies heavily rely on biobanks to access high-quality samples and associated data, thereby accelerating their research and development efforts.
Global Biobanks Market Analysis
The global biobanks market size was $72.7 billion in 2022 and is predicted to grow with a CAGR of 8.8%, by generating a revenue of $164.9 billion by 2032.
COVID-19 Impact on Global Biobanks Market
The COVID-19 pandemic had a major impact on the biobanks market. During the pandemic, the demand for biobanking services and sample collections increased as researchers sought to better understand the virus and its effects on the human body. Biobanks played a pivotal role in storing and providing access to samples from COVID-19 patients, which enabled researchers to study the virus's behaviour, identify potential treatments, and develop vaccines. The pandemic also presented several challenges for biobanks. Ensuring the safety and integrity of collected samples became a top priority, as the virus's transmission raised concerns about handling potentially infectious materials. Biobanks had to implement strict protocols and guidelines to protect their staff and maintain sample quality.
Despite these challenges, the COVID-19 pandemic also brought opportunities for growth in the biobanking market. Governments, organizations, and investors recognized the critical importance of biobanks in managing public health crises. This awareness led to increased investments in biobanking infrastructure and capabilities, fuelling innovation in sample storage, data management, and collaboration networks. Increased recognition and investment in biobanking infrastructure are expected to drive further advancements and collaborations in the market in the post-pandemic era.
Significance of Biobanks in Advancing Medical Research and Personalized Medicine to Drive Market Growth
Biobanks play a crucial role in advancing medical research by providing a vast collection of biological samples for scientific studies. These repositories enable researchers to access a diverse range of specimens facilitating a more comprehensive understanding of diseases and their underlying mechanisms. Biobanks aid in personalized medicine development as they store genetic and health information that can be utilized for tailoring treatments to individual patients. Through efficient sample storage and management and biobanks contribute to preserving valuable biological resources for future research endeavours. Collaborative efforts between various biobanks enhance knowledge sharing and promote global scientific progress.
Ethical and Practical Considerations in Biobanking and Research Studies to Restrain the Market Growth
Privacy concerns arise due to the sensitive nature of the stored data, necessitating stringent ethical guidelines to safeguard participants' confidentiality. Ensuring the representativeness and diversity of samples can be challenging, potentially leading to biased outcomes in research studies. Maintaining the long-term viability of biological specimens requires meticulous preservation techniques, which can be resource intensive. Ethical dilemmas may emerge regarding the ownership and consent for the usage of stored samples, demanding careful governance and consent protocols. Financial sustainability can be a concern, as biobanks often rely on funding and support to maintain operations and expand their offerings.
Advancements in Biobanks to Drive Excellent Opportunities for Future
Embracing advanced technologies such as AI and automation can streamline sample handling, analysis, and data management, thus optimizing efficiency. Moreover, growing collaboration between biobanks and healthcare institutions are likely to promote the integration of clinical data with biological samples for more comprehensive research. Also, the implementation of blockchain or similar secure systems in biobanks to address privacy concerns and provide participants with greater control over their data can boost the growth of biobanks market. In addition, encouraging public engagement and offering education about the significance of biobanks in scientific advancements to foster trust and support can also contribute to the market expansion.
Global Biobanks Market, by Product, 2022
The biobanking equipment sub-segment accounted for the highest market share in 2022. Biobanking equipment holds a dominant position in the biobank industry due to its crucial role in preserving and storing valuable biological samples. These tools and devices enable researchers to maintain the integrity and viability of specimens such as tissues & blood and DNA for future studies and analysis. Such equipment guarantees the long-term stability of these samples and ensures their availability for a wide range of scientific investigations. By securely storing these materials, biobanking equipment facilitates breakthrough research and medical advancements, contributing significantly to the progress of various fields like genetics, medicine, and environmental science. Its importance lies in the preservation of valuable biological resources that can be utilized for understanding diseases, developing personalized therapies, and conducting cutting-edge research for the betterment of humankind.
Global Biobanks Market, by Service, 2022
The biobanking and repository services sub-segment accounted for the highest market share in 2022. These services are crucial for researchers and medical professionals to access high-quality specimens (samples) such as tissues, blood, and DNA. By offering a secure and organized facility for long-term storage, biobanks ensure the integrity and longevity of these specimens (samples). The significance of biobanking lies in the diverse applications it serves. Researchers can use the stored samples (specimens) to advance scientific knowledge, study diseases, and develop new treatments. This wealth of data (information) contributes to medical breakthroughs and enhances healthcare practices. Moreover, biobanks adhere to rigorous protocols to maintain sample (specimen) quality, traceability, and confidentiality. These stringent measures instill trust and confidence in both donors and end-users. Researchers can be confident that the samples they obtain are of high quality and accurately represent the population they aim to study.
Global Biobanks Market, by Biospecimen Type, 2022
The human tissues sub-segment accounted for the highest market share in 2022. Human tissues are commonly considered the predominant biospecimen in biobanks due to their intrinsic value in medical research. These tissues offer a wealth of information about human biology & diseases and responses to treatments, making them highly sought-after by researchers. Their significance lies in their direct relevance to human health which enables scientists to study various aspects of diseases and genetics and drug testing.
Global Biobanks Market, by Biobank Type, 2022
The physical/real biobank sub-segment accounted for the highest market share in 2022. Real biobanks are considered the prevailing type due to their tangible presence and direct connection to physical samples. These biobanks store actual biological materials like tissues and blood samples which makes them invaluable resources for researchers in various fields. Unlike virtual biobanks which rely on data alone real biobanks provide a wealth of authentic and diverse specimens for scientific exploration. This hands-on approach allows scientists to perform more comprehensive and reliable studies and facilitate groundbreaking discoveries and advancements in medical research (e.g., disease understanding and treatment development). Moreover, real biobanks adhere to rigorous ethical and regulatory standards which ensure the responsible and confidential handling of sensitive biological materials.
Global Biobanks Market, by Application, 2022
The therapeutics sub-segment accounted for the highest market share in 2022. The dominance of therapeutics as the primary application of biobanks can be attributed to their significant role in advancing medical research and healthcare. Biobanks play a crucial part in the discovery and development and in validation of potential treatments and drugs for various diseases. They serve as repositories of biological samples such as tissues & cells and DNA collected from diverse populations. This diverse and extensive collection enables researchers to access a wealth of genetic and molecular information which facilitates the identification of biomarkers & disease mechanisms and potential drug targets. By utilizing these samples scientists can conduct studies that lead to a better understanding of diseases enabling the development of targeted therapies.
Global Biobanks Market Share, by Region, 2022
The Europe biobanks market generated the highest market share in 2022. European countries have strong regulatory frameworks and ethical guidelines which have fostered trust and confidence in biobanking practices. Europe is a popular destination for scientists looking for genetic and health data due to its big and diverse population.
European countries have a long history of scientific research collaboration and have built up sizable networks for cross-border exchange of biobank data. This cooperation allows researchers to access a larger dataset, leading to more comprehensive and robust findings. The general population often perceives biobanking to contribute to advancements in healthcare and scientific knowledge, further bolstering participation rates. Overall, Europe's regulatory environment, diverse population, collaborative research networks, prestigious institutions, and strong public engagement have collectively established the region as a leading force in the utilization of biobanks for advancing medical research and improving healthcare outcomes.
Competitive Scenario in the Global Biobanks Market
Investment and agreement are common strategies followed by major market players. Some of the leading biobanks market players are Thermo Fisher Scientific, Inc., Merck KGaA, QIAGEN, Hamilton Company, Avantor, Tecan Trading AG., Danaher Corporation, Becton, Dickinson, and Company (BD), BioCision, and Taylor-Wharton.
| Aspect | Particular |
| Historical Market Estimations | 2020-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Product |
|
| Segmentation by Service |
|
| Segmentation by Biospecimen Type |
|
| Segmentation by Biobanks Type |
|
| Segmentation by Application |
|
| Key Companies Profiled |
|
Q1. What is the size of the global biobanks market?
A. The size of the global biobanks market was over $72.7 billion in 2022 and is projected to reach $164.9 billion by 2032.
Q2. Which are the major companies in the biobanks market?
A. Tecan Trading AG., Danaher Corporation, Becton, Dickinson, and Company (BD), BioCision, and Taylor-Wharton are the major companies in the biobanks market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The Europe region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Agreement and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Tecan Trading AG., Danaher Corporation, Becton, Dickinson, and Company (BD), BioCision, and Taylor-Wharton are investing more on R&D practices.
1. Research Methodology
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model.
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
2. Report Scope
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Biobanks Market
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Biobanks Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
5. Biobanks Market, by Product
5.1. Overview
5.2. Biobanking Equipment
5.2.1. Definition, key trends, growth factors, and opportunities
5.2.2. Market size analysis, by region, 2022-2032
5.2.3. Market share analysis, by country, 2022-2032
5.3. Biobanking Consumables
5.3.1. Definition, key trends, growth factors, and opportunities
5.3.2. Market size analysis, by region, 2022-2032
5.3.3. Market share analysis, by country, 2022-2032
5.4. Laboratory Information Management Systems
5.4.1. Definition, key trends, growth factors, and opportunities
5.4.2. Market size analysis, by region, 2022-2032
5.4.3. Market share analysis, by country, 2022-2032
5.5. Research Dive Exclusive Insights
5.5.1. Market attractiveness
5.5.2. Competition heatmap
6. Biobanks Market by Product, by Service
6.1. Overview
6.2. Biobanking & Repository
6.2.1. Definition, key trends, growth factors, and opportunities
6.2.2. Market size analysis, by region, 2022-2032
6.2.3. Market share analysis, by country, 2022-2032
6.3. Lab Processing
6.3.1. Definition, key trends, growth factors, and opportunities
6.3.2. Market size analysis, by region, 2022-2032
6.3.3. Market share analysis, by country, 2022-2032
6.4. Qualification/ Validation
6.4.1. Definition, key trends, growth factors, and opportunities
6.4.2. Market size analysis, by region, 2022-2032
6.4.3. Market share analysis, by country, 2022-2032
6.5. Cold Chain Logistics
6.5.1. Definition, key trends, growth factors, and opportunities
6.5.2. Market size analysis, by region, 2022-2032
6.5.3. Market share analysis, by country, 2022-2032
6.6. Other Services
6.6.1. Definition, key trends, growth factors, and opportunities
6.6.2. Market size analysis, by region, 2022-2032
6.6.3. Market share analysis, by country, 2022-2032
6.7. Research Dive Exclusive Insights
6.7.1. Market attractiveness
6.7.2. Competition heatmap
7. Biobanks Market by Product, by Biobank Type
7.1. Overview
7.2. Physical/Real Biobanks
7.2.1. Definition, key trends, growth factors, and opportunities
7.2.2. Market size analysis, by region, 2022-2032
7.2.3. Market share analysis, by country, 2022-2032
7.3. Virtual Biobanks
7.3.1. Definition, key trends, growth factors, and opportunities
7.3.2. Market size analysis, by region, 2022-2032
7.3.3. Market share analysis, by country, 2022-2032
7.4. Research Dive Exclusive Insights
7.4.1. Market attractiveness
7.4.2. Competition heatmap
8. Biobanks Market by Product, by Biobank Type
8.1. Overview
8.2. Physical/Real Biobanks
8.2.1. Definition, key trends, growth factors, and opportunities
8.2.2. Market size analysis, by region, 2022-2032
8.2.3. Market share analysis, by country, 2022-2032
8.3. Virtual Biobanks
8.3.1. Definition, key trends, growth factors, and opportunities
8.3.2. Market size analysis, by region, 2022-2032
8.3.3. Market share analysis, by country, 2022-2032
8.4. Research Dive Exclusive Insights
8.4.1. Market attractiveness
8.4.2. Competition heatmap
9. Biobanks Market by Product, by Application
9.1. Overview
9.2. Therapeutics
9.2.1. Definition, key trends, growth factors, and opportunities
9.2.2. Market size analysis, by region, 2022-2032
9.2.3. Market share analysis, by country, 2022-2032
9.3. Drug Discovery & Clinical Research
9.3.1. Definition, key trends, growth factors, and opportunities
9.3.2. Market size analysis, by region, 2022-2032
9.3.3. Market share analysis, by country, 2022-2032
9.4. Clinical Diagnostics
9.4.1. Definition, key trends, growth factors, and opportunities
9.4.2. Market size analysis, by region, 2022-2032
9.4.3. Market share analysis, by country, 2022-2032
9.5. Other Applications
9.5.1. Definition, key trends, growth factors, and opportunities
9.5.2. Market size analysis, by region, 2022-2032
9.5.3. Market share analysis, by country, 2022-2032
9.6. Research Dive Exclusive Insights
9.6.1. Market attractiveness
9.6.2. Competition heatmap
10. Biobanks Market, by Region
10.1. North America
10.1.1. U.S.
10.1.1.1. Market size analysis, by Product
10.1.1.2. Market size analysis, by Service
10.1.1.3. Market size analysis, by Biospecimen Type
10.1.1.4. Market size analysis, by Biobanks Type
10.1.1.5. Market size analysis, by Applications
10.1.2. Canada
10.1.2.1. Market size analysis, by Product
10.1.2.2. Market size analysis, by Service
10.1.2.3. Market size analysis, by Biospecimen Type
10.1.2.4. Market size analysis, by Biobanks Type
10.1.2.5. Market size analysis, by Applications
10.1.3. Mexico
10.1.3.1. Market size analysis, by Product
10.1.3.2. Market size analysis, by Service
10.1.3.3. Market size analysis, by Biospecimen Type
10.1.3.4. Market size analysis, by Biobanks Type
10.1.3.5. Market size analysis, by Applications
10.1.4. Research Dive Exclusive Insights
10.1.4.1. Market attractiveness
10.1.4.2. Competition heatmap
10.2. Europe
10.2.1. Germany
10.2.1.1. Market size analysis, by Product
10.2.1.2. Market size analysis, by Service
10.2.1.3. Market size analysis, by Biospecimen Type
10.2.1.4. Market size analysis, by Biobanks Type
10.2.1.5. Market size analysis, by Applications
10.2.2. UK
10.2.2.1. Market size analysis, by Product
10.2.2.2. Market size analysis, by Service
10.2.2.3. Market size analysis, by Biospecimen Type
10.2.2.4. Market size analysis, by Biobanks Type
10.2.2.5. Market size analysis, by Applications
10.2.3. France
10.2.3.1. Market size analysis, by Product
10.2.3.2. Market size analysis, by Service
10.2.3.3. Market size analysis, by Biospecimen Type
10.2.3.4. Market size analysis, by Biobanks Type
10.2.3.5. Market size analysis, by Applications
10.2.4. Spain
10.2.4.1. Market size analysis, by Product
10.2.4.2. Market size analysis, by Service
10.2.4.3. Market size analysis, by Biospecimen Type
10.2.4.4. Market size analysis, by Biobanks Type
10.2.4.5. Market size analysis, by Applications
10.2.5. Italy
10.2.5.1. Market size analysis, by Product
10.2.5.2. Market size analysis, by Service
10.2.5.3. Market size analysis, by Biospecimen Type
10.2.5.4. Market size analysis, by Biobanks Type
10.2.5.5. Market size analysis, by Applications
10.2.6. Rest of Europe
10.2.6.1. Market size analysis, by Product
10.2.6.2. Market size analysis, by Service
10.2.6.3. Market size analysis, by Biospecimen Type
10.2.6.4. Market size analysis, by Biobanks Type
10.2.6.5. Market size analysis, by Applications
10.2.7. Research Dive Exclusive Insights
10.2.7.1. Market attractiveness
10.2.7.2. Competition heatmap
10.3. Asia Pacific
10.3.1. China
10.3.1.1. Market size analysis, by Product
10.3.1.2. Market size analysis, by Service
10.3.1.3. Market size analysis, by Biospecimen Type
10.3.1.4. Market size analysis, by Biobanks Type
10.3.1.5. Market size analysis, by Applications
10.3.2. Japan
10.3.2.1. Market size analysis, by Product
10.3.2.2. Market size analysis, by Service
10.3.2.3. Market size analysis, by Biospecimen Type
10.3.2.4. Market size analysis, by Biobanks Type
10.3.2.5. Market size analysis, by Applications
10.3.3. India
10.3.3.1. Market size analysis, by Product
10.3.3.2. Market size analysis, by Service
10.3.3.3. Market size analysis, by Biospecimen Type
10.3.3.4. Market size analysis, by Biobanks Type
10.3.3.5. Market size analysis, by Applications
10.3.4. Australia
10.3.4.1. Market size analysis, by Product
10.3.4.2. Market size analysis, by Service
10.3.4.3. Market size analysis, by Biospecimen Type
10.3.4.4. Market size analysis, by Biobanks Type
10.3.4.5. Market size analysis, by Applications
10.3.5. South Korea
10.3.5.1. Market size analysis, by Product
10.3.5.2. Market size analysis, by Service
10.3.5.3. Market size analysis, by Biospecimen Type
10.3.5.4. Market size analysis, by Biobanks Type
10.3.5.5. Market size analysis, by Applications
10.3.6. Rest of Asia Pacific
10.3.6.1. Market size analysis, by Product
10.3.6.2. Market size analysis, by Service
10.3.6.3. Market size analysis, by Biospecimen Type
10.3.6.4. Market size analysis, by Biobanks Type
10.3.6.5. Market size analysis, by Applications
10.3.7. Research Dive Exclusive Insights
10.3.7.1. Market attractiveness
10.3.7.2. Competition heatmap
10.4. LAMEA
10.4.1. Brazil
10.4.1.1. Market size analysis, by Product
10.4.1.2. Market size analysis, by Service
10.4.1.3. Market size analysis, by Biospecimen Type
10.4.1.4. Market size analysis, by Biobanks Type
10.4.1.5. Market size analysis, by Applications
10.4.2. Saudi Arabia
10.4.2.1. Market size analysis, by Product
10.4.2.2. Market size analysis, by Service
10.4.2.3. Market size analysis, by Biospecimen Type
10.4.2.4. Market size analysis, by Biobanks Type
10.4.2.5. Market size analysis, by Applications
10.4.3. UAE
10.4.3.1. Market size analysis, by Product
10.4.3.2. Market size analysis, by Service
10.4.3.3. Market size analysis, by Biospecimen Type
10.4.3.4. Market size analysis, by Biobanks Type
10.4.3.5. Market size analysis, by Applications
10.4.4. South Africa
10.4.4.1. Market size analysis, by Product
10.4.4.2. Market size analysis, by Service
10.4.4.3. Market size analysis, by Biospecimen Type
10.4.4.4. Market size analysis, by Biobanks Type
10.4.4.5. Market size analysis, by Applications
10.4.5. Rest of LAMEA
10.4.5.1. Market size analysis, by Product
10.4.5.2. Market size analysis, by Service
10.4.5.3. Market size analysis, by Biospecimen Type
10.4.5.4. Market size analysis, by Biobanks Type
10.4.5.5. Market size analysis, by Applications
10.4.6. Research Dive Exclusive Insights
10.4.6.1. Market attractiveness
10.4.6.2. Competition heatmap
11. Competitive Landscape
11.1. Top winning strategies, 2022
11.1.1. By strategy
11.1.2. By year
11.2. Strategic overview
11.3. Market share analysis, 2022
12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Overview
12.1.2. Business segments
12.1.3. Product portfolio
12.1.4. Financial performance
12.1.5. Recent developments
12.1.6. Audi
12.2. Merck KGaA
12.2.1. Overview
12.2.2. Business segments
12.2.3. Product portfolio
12.2.4. Financial performance
12.2.5. Recent developments
12.2.6. SWOT analysis
12.3. QIAGEN
12.3.1. Overview
12.3.2. Business segments
12.3.3. Product portfolio
12.3.4. Financial performance
12.3.5. Recent developments
12.3.6. SWOT analysis
12.4. Hamilton Company
12.4.1. Overview
12.4.2. Business segments
12.4.3. Product portfolio
12.4.4. Financial performance
12.4.5. Recent developments
12.4.6. SWOT analysis
12.5. Avantor.
12.5.1. Overview
12.5.2. Business segments
12.5.3. Product portfolio
12.5.4. Financial performance
12.5.5. Recent developments
12.5.6. SWOT analysis
12.6. Tecan Trading AG.
12.6.1. Overview
12.6.2. Business segments
12.6.3. Product portfolio
12.6.4. Financial performance
12.6.5. Recent developments
12.6.6. SWOT analysis
12.7. Danaher Corporation
12.7.1. Overview
12.7.2. Business segments
12.7.3. Product portfolio
12.7.4. Financial performance
12.7.5. Recent developments
12.7.6. SWOT analysis
12.7.7. Becton, Dickinson, and Company (BD) Overview
12.7.8. Business segments
12.7.9. Product portfolio
12.7.10. Financial performance
12.7.11. Recent developments
12.7.12. SWOT analysis
12.8. BioCision
12.8.1. Overview
12.8.2. Business segments
12.8.3. Product portfolio
12.8.4. Financial performance
12.8.5. Recent developments
12.8.6. SWOT analysis
12.9. Taylor-Wharton
12.9.1. Overview
12.9.2. Business segments
12.9.3. Product portfolio
12.9.4. Financial performance
12.9.5. Recent developments
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
